Celldex (CLDX) Misses Q4 EPS by 7c

Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.83), $0.07 worse than the analyst estimate of ($0.76). Revenue for the quarter came in at $4.13 million versus the consensus estimate of $855.71 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Worthington Steel, Inc. (WS) Misses Q4 EPS by 3c
• Barclays Downgrades Brown Forman (BF-B) to Equalweight
• H.B. Fuller makes £715M cash offer to acquire Advanced Medical Solutions